Svb Wealth LLC Merck & Co., Inc. Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $870,066 - $934,442	-7,028 Reduced 5.75%	115,158 $14.3 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $578,656 - $674,264	-5,110 Reduced 4.01%	122,186 $16.1 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $1.22 Million - $1.33 Million	-12,226 Reduced 8.76%	127,296 $13.9 Million
Q3 2023 Oct 23, 2023	SELL	$102.95 - $114.33 $1.09 Million - $1.21 Million	-10,552 Reduced 7.03%	139,522 $14.4 Million
Q2 2023 Jul 24, 2023	SELL	$108.61 - $118.38 $4.87 Million - $5.31 Million	-44,877 Reduced 23.02%	150,074 $17.3 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $31.2 Million - $34.9 Million	-303,501 Reduced 60.89%	194,951 $20.7 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $2.62 Million - $3.36 Million	-29,977 Reduced 5.67%	498,452 $55.3 Million
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $2.43 Million - $2.73 Million	28,757 Added 5.76%	528,429 $45.5 Million
Q2 2022 Aug 16, 2022	BUY	$83.49 - $94.64 $170,069 - $192,781	2,037 Added 0.41%	499,672 $45.6 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $1.51 Million - $1.69 Million	20,568 Added 4.31%	497,635 $40.8 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $77,195 - $96,696	-1,068 Reduced 0.22%	477,067 $36.6 Million
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $456,458 - $501,989	-6,368 Reduced 1.31%	478,135 $35.9 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $339,456 - $375,473	4,828 Added 1.01%	484,503 $37.7 Million
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $33 Million - $38.9 Million	-479,094 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $705,929 - $783,437	-9,836 Reduced 2.01%	479,094 $39.2 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $4.04 Million - $4.58 Million	-55,168 Reduced 10.14%	488,930 $40.6 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $1.06 Million - $1.2 Million	15,028 Added 2.84%	544,098 $42.1 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $566,375 - $785,022	8,939 Added 1.72%	529,070 $40.7 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $646,008 - $728,945	8,327 Added 1.63%	520,131 $47.3 Million
Q3 2019 Nov 01, 2019	SELL	$76.08 - $82.93 $717,662 - $782,278	-9,433 Reduced 1.81%	511,804 $43.1 Million
Q2 2019 Jul 10, 2019	SELL	$69.84 - $81.59 $1.94 Million - $2.26 Million	-27,724 Reduced 5.05%	521,237 $43.7 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $1.26 Million - $1.44 Million	-18,162 Reduced 3.2%	548,961 $45.7 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $1.05 Million - $1.22 Million	-16,069 Reduced 2.76%	567,123 $43.3 Million
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $337,024 - $396,321	5,842 Added 1.01%	583,192 $41.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $1.38 Million - $1.62 Million	-27,120 Reduced 4.49%	577,350 $35 Million
Q1 2018 May 11, 2018	SELL	$50.96 - $59.23 $114,150 - $132,675	-2,240 Reduced 0.37%	604,470 $32.9 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $2.11 Million - $2.52 Million	-40,861 Reduced 6.31%	606,710 $34.1 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $38 Million - $40.9 Million	647,571	647,571 $41.5 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.6 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.8 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.52 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.87 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account